Could a second steroid boost survival in septic shock? tiny trial paves way

NCT ID NCT07451886

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This pilot study tests whether adding fludrocortisone (a steroid pill) to standard hydrocortisone treatment helps people with septic shock. Only 32 critically ill adults will take part. The main goal is not to see if the combo works, but to check if a larger, more definitive trial is possible.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Fludrocortisone (a steroid hormone) given as a pill, plus standard hydrocortisone (another steroid) given intravenously
What this could lead to
If this pilot shows the larger trial is feasible, it could lead to a definitive study that may prove adding fludrocortisone saves more lives from septic shock.
What could go wrong
This is a very small pilot (32 patients) testing only whether a larger trial can be done, not whether the drug works. Even if the larger trial happens, the combination may not reduce deaths.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • North District Hospital

    NOT_YET_RECRUITING

    Hong Kong, Hong Kong

  • Pamela Youde Nethersole Hospital

    NOT_YET_RECRUITING

    Hong Kong, Hong Kong

  • Prince of Wales Hospital

    RECRUITING

    Hong Kong, Hong Kong

  • Princess Margaret Hospital

    NOT_YET_RECRUITING

    Hong Kong, Hong Kong

  • Queen Mary Hospital

    NOT_YET_RECRUITING

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.